Announcement of Meeting of the Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030, 15361-15362 [2017-06033]
Download as PDF
Federal Register / Vol. 82, No. 58 / Tuesday, March 28, 2017 / Notices
15361
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Portion of study
Number of
responses
per
respondent
Total
annual
responses
Screening for pretest ....................................
Pretest ...........................................................
Screening for main data collection ...............
Main data collection ......................................
762
100
19,082
2,500
1
1
1
1
762
100
19,082
2,500
Total .......................................................
........................
........................
........................
sradovich on DSK3GMQ082PROD with NOTICES
1 There
Average
burden per
response
.033 (2
.25 (15
.033 (2
.25 (15
minutes)
minutes)
minutes)
minutes)
Total hours
...................
...................
...................
...................
25
25
630
625
...............................................
1,305
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA’s burden estimate is based on
prior experience with research that is
similar to this proposed study.
Screening potential participants for the
2 pretests will occur with 762
respondents (487 adults and 275
adolescents) identified and recruited
through the Internet panel. This brief
screening will take an average of 2
minutes (0.033 hours) per respondent.
Each of the 2 pretests will consist of 50
respondents (34 adults and 16
adolescents) conducted during a single
session and take an average of 15
minutes (0.25 hours) per respondent.
Screening potential participants for the
main data collection will occur with
19,082 respondents (11,925 adults and
7,157 adolescents) identified and
recruited through the same Internet
panel as used for the pretests. This brief
screening will take an average of 2
minutes (0.033 hours) per respondent.
Recent national estimates of the
numbers of adolescent current cigarette
smokers, adolescents who are
susceptible to initiation of cigarette
smoking, young adult current cigarette
smokers, and older adult current
cigarette smokers informed the
estimates of 13.9 percent qualification
rate for adults and 11.6 percent
qualification rate for adolescents.
Applying these estimates and other
assumptions from previous experience
conducting similar studies to the
number of adolescents and adults to be
screened results in the desired sample
size for the main data collection of 2,500
participants, of which 1,667 will be
adults and 833 will be adolescents. The
main data collection will occur with
those 2,500 respondents during a single
session. The main data collection will
take an average of 15 minutes (0.25
hours) per respondent. The total
estimated burden is 1,305 hours (25
hours + 25 hours + 630 hours + 625
hours).
VerDate Sep<11>2014
17:14 Mar 27, 2017
Jkt 241001
Dated: March 22, 2017.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2017–06078 Filed 3–27–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of Meeting of the
Secretary’s Advisory Committee on
National Health Promotion and Disease
Prevention Objectives for 2030
Office of Disease Prevention
and Health Promotion, Office of the
Assistant Secretary for Health, Office of
the Secretary, Department of Health and
Human Services.
AGENCY:
ACTION:
Notice.
The U.S. Department of
Health and Human Services (HHS)
announces the next federal advisory
committee meeting regarding the
development of national health
promotion and disease prevention
objectives for 2030. This meeting will be
held online via webinar and is open to
the public. The Committee will discuss
the nation’s health promotion and
disease prevention objectives and will
provide recommendations to improve
health status and reduce health risks for
the nation by the year 2030. The
Committee will advise the Secretary on
the Healthy People 2030 mission,
vision, framework, and organizational
structure. The Committee will provide
advice regarding criteria for identifying
a more focused set of measurable,
nationally representative objectives. The
Committee’s advice must assist the
Secretary in reducing the number of
objectives while ensuring that the
selection criteria identifies the most
critical public health issues that are
high-impact priorities supported by
current national data.
SUMMARY:
The Committee will meet on
April 27, 2017, from 12:00 p.m. to 2:00
p.m. Eastern Time (ET).
DATES:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
The meeting will be held
online via webinar. To register to attend
the meeting, please visit the Healthy
People Web site at https://
www.healthypeople.gov.
FOR FURTHER INFORMATION CONTACT:
Emmeline Ochiai, Designated Federal
Officer, Secretary’s Advisory Committee
on National Health Promotion and
Disease Prevention Objectives for 2030,
U.S. Department of Health and Human
Services, Office of the Assistant
Secretary for Health, Office of Disease
Prevention and Health Promotion, 1101
Wootton Parkway, Room LL–100,
Rockville, MD 20852, (240) 453–8280
(telephone), (240) 453–8281 (fax).
Additional information is available on
the Healthy People Web site at https://
www.healthypeople.gov.
SUPPLEMENTARY INFORMATION: The
names and biographies of the
Committee members are available at
https://www.healthypeople.gov/2020/
about/history-development/healthypeople-2030-advisory-committee.
Purpose of Meeting: Through the
Healthy People initiative, HHS leverages
scientific insights and lessons from the
past decade, along with new knowledge
of current data, trends, and innovations,
to develop the next iteration of national
health promotion and disease
prevention objectives. Healthy People
provides science-based, 10-year national
objectives for promoting health and
preventing disease. Since 1979, Healthy
People has set and monitored national
health objectives that meet a broad
range of health needs, encourage
collaboration across sectors, guide
individuals toward making informed
health decisions, and measure the
impact of our prevention and health
promotion activities. Healthy People
2030 health objectives will reflect
assessments of major risks to health and
wellness, changing public health
priorities, and emerging technologies
related to our nation’s health
preparedness and prevention.
Public Participation at Meeting:
Members of the public are invited to
ADDRESSES:
E:\FR\FM\28MRN1.SGM
28MRN1
15362
Federal Register / Vol. 82, No. 58 / Tuesday, March 28, 2017 / Notices
join the online Committee meeting.
There will be no opportunity for oral
public comments during this online
Committee meeting. However, written
comments are welcome throughout the
entire development process of the
national health promotion and disease
prevention objectives for 2030 and may
be emailed to HP2030@hhs.gov.
To join the Committee meeting,
individuals must pre-register at the
Healthy People Web site at https://
www.healthypeople.gov. Participation in
the meeting is limited. Registrations will
be accepted until maximum webinar
capacity is reached and must be
completed by 9:00 a.m. ET on April 26,
2017. A waiting list will be maintained
should registrations exceed capacity,
and those individuals will be contacted
as additional space for the meeting
becomes available. Registration
questions may be directed to: Jim
Nakayama at events@
nakamotogroup.com, or (240) 672–4011.
Date: March 29, 2017.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W104, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Eun Ah Cho, Ph.D., Chief,
Special Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W104, Bethesda, MD 20892–9750,
240–276–6342, choe@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Authority: 42 U.S.C. 217a. The Secretary’s
Advisory Committee on National Health
Promotion and Disease Prevention Objectives
for 2030 is governed by provisions of the
Federal Advisory Committee Act (FACA),
Public Law 92–463, as amended (5 U.S.C.,
App.) which sets forth standards for the
formation and use of federal advisory
committees.
Dated: March 22, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: March 10, 2017.
Don Wright,
Deputy Assistant Secretary for Health
(Disease Prevention and Health Promotion).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–06033 Filed 3–27–17; 8:45 am]
National Library of Medicine; Notice of
Meeting
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sradovich on DSK3GMQ082PROD with NOTICES
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Provocative Question #10.
VerDate Sep<11>2014
17:14 Mar 27, 2017
Jkt 241001
[FR Doc. 2017–06039 Filed 3–27–17; 8:45 am]
BILLING CODE 4140–01–P
20894, 301–435–5985, dlipman@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program No. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS).
Dated: March 22, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06045 Filed 3–27–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
National Institutes of Health
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of a meeting of the
PubMed Central National Advisory
Committee.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: PubMed Central
National Advisory Committee.
Date: June 21, 2017.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: Review and Analysis of Systems.
Place: National Library of Medicine,
Building 38, 2nd Floor, The Lindberg Room,
8600 Rockville Pike, Building 38, Conference
Room B, Bethesda, MD 20892
(Teleconference).
Contact Person: David J. Lipman, MD,
Director, National Center for Biotechnology
Information, National Library of Medicine,
Building 38, Room 8N807, Bethesda, MD
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2); notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
meeting is to evaluate requests for
preclinical development resources for
potential new therapeutics for the
treatment of cancer. The outcome of the
evaluation will provide information to
internal NCI committees that will
decide whether NCI should support
requests and make available contract
resources for development of the
potential therapeutic to improve the
treatment of various forms of cancer.
The research proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
E:\FR\FM\28MRN1.SGM
28MRN1
Agencies
[Federal Register Volume 82, Number 58 (Tuesday, March 28, 2017)]
[Notices]
[Pages 15361-15362]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06033]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Announcement of Meeting of the Secretary's Advisory Committee on
National Health Promotion and Disease Prevention Objectives for 2030
AGENCY: Office of Disease Prevention and Health Promotion, Office of
the Assistant Secretary for Health, Office of the Secretary, Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The U.S. Department of Health and Human Services (HHS)
announces the next federal advisory committee meeting regarding the
development of national health promotion and disease prevention
objectives for 2030. This meeting will be held online via webinar and
is open to the public. The Committee will discuss the nation's health
promotion and disease prevention objectives and will provide
recommendations to improve health status and reduce health risks for
the nation by the year 2030. The Committee will advise the Secretary on
the Healthy People 2030 mission, vision, framework, and organizational
structure. The Committee will provide advice regarding criteria for
identifying a more focused set of measurable, nationally representative
objectives. The Committee's advice must assist the Secretary in
reducing the number of objectives while ensuring that the selection
criteria identifies the most critical public health issues that are
high-impact priorities supported by current national data.
DATES: The Committee will meet on April 27, 2017, from 12:00 p.m. to
2:00 p.m. Eastern Time (ET).
ADDRESSES: The meeting will be held online via webinar. To register to
attend the meeting, please visit the Healthy People Web site at https://www.healthypeople.gov.
FOR FURTHER INFORMATION CONTACT: Emmeline Ochiai, Designated Federal
Officer, Secretary's Advisory Committee on National Health Promotion
and Disease Prevention Objectives for 2030, U.S. Department of Health
and Human Services, Office of the Assistant Secretary for Health,
Office of Disease Prevention and Health Promotion, 1101 Wootton
Parkway, Room LL-100, Rockville, MD 20852, (240) 453-8280 (telephone),
(240) 453-8281 (fax). Additional information is available on the
Healthy People Web site at https://www.healthypeople.gov.
SUPPLEMENTARY INFORMATION: The names and biographies of the Committee
members are available at https://www.healthypeople.gov/2020/about/history-development/healthy-people-2030-advisory-committee.
Purpose of Meeting: Through the Healthy People initiative, HHS
leverages scientific insights and lessons from the past decade, along
with new knowledge of current data, trends, and innovations, to develop
the next iteration of national health promotion and disease prevention
objectives. Healthy People provides science-based, 10-year national
objectives for promoting health and preventing disease. Since 1979,
Healthy People has set and monitored national health objectives that
meet a broad range of health needs, encourage collaboration across
sectors, guide individuals toward making informed health decisions, and
measure the impact of our prevention and health promotion activities.
Healthy People 2030 health objectives will reflect assessments of major
risks to health and wellness, changing public health priorities, and
emerging technologies related to our nation's health preparedness and
prevention.
Public Participation at Meeting: Members of the public are invited
to
[[Page 15362]]
join the online Committee meeting. There will be no opportunity for
oral public comments during this online Committee meeting. However,
written comments are welcome throughout the entire development process
of the national health promotion and disease prevention objectives for
2030 and may be emailed to HP2030@hhs.gov.
To join the Committee meeting, individuals must pre-register at the
Healthy People Web site at https://www.healthypeople.gov. Participation
in the meeting is limited. Registrations will be accepted until maximum
webinar capacity is reached and must be completed by 9:00 a.m. ET on
April 26, 2017. A waiting list will be maintained should registrations
exceed capacity, and those individuals will be contacted as additional
space for the meeting becomes available. Registration questions may be
directed to: Jim Nakayama at events@nakamotogroup.com, or (240) 672-
4011.
Authority: 42 U.S.C. 217a. The Secretary's Advisory Committee on
National Health Promotion and Disease Prevention Objectives for 2030
is governed by provisions of the Federal Advisory Committee Act
(FACA), Public Law 92-463, as amended (5 U.S.C., App.) which sets
forth standards for the formation and use of federal advisory
committees.
Dated: March 10, 2017.
Don Wright,
Deputy Assistant Secretary for Health (Disease Prevention and Health
Promotion).
[FR Doc. 2017-06033 Filed 3-27-17; 8:45 am]
BILLING CODE 4150-32-P